Intuitive Surgical Inc (ISRG) FY2025Q4 Earning Prediction
Intuitive Surgical Inc (ISRG) is set to release its FY2025Q4 earnings performance on 01/22 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 3.00B and an earnings per share (EPS) of 2.26 for the FY2025Q4. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
AI Earnings Prediction
The earnings forecast indicates a Beat driven by strong procedure growth and system utilization improvements, though elevated valuations may limit the upside.
Scenario Analysis
Key Indicators Forecast
No data
Prediction Logic & Rational
Logic & Justification
Key Fact Data Drivers:
- Procedure Growth Exceeds Expectations:
Q4 2025 worldwide procedures grew 18% YoY, with da Vinci procedures up 17% and Ion procedures surging 44% (Fact Data: Pre-announcement). This significantly addresses the core market concern around procedure growth sustainability and system adoption.
Ion’s 44% growth suggests strong momentum in lung biopsy adoption, a key growth driver.
- System Utilization Growth:
- Da Vinci utilization increased 4% YoY, driven by Dv5 adoption in the U.S. and international markets. Higher utilization directly supports recurring revenue (instruments & accessories), which accounts for ~70% of total revenue.
- Dv5 Launch Impact:
- BTIG estimates Dv5 contributes 25% of FY26 revenue growth, with incremental benefits to both System sales and recurring I&A revenue (Fact Data: Analyst notes).
- Regulatory Tailwinds:
FDA clearance for da Vinci Single Port in new procedures (hernia repair, cholecystectomy) expands addressable markets and supports procedure volume growth.
Cautions:The stock dropped 6% post-pre-announcement, suggesting some investors may have priced in even stronger results or are concerned about margins.
Citi’s downgrade to Neutral and Freedom Capital’s Hold rating cite valuation risks, implying expectations are already elevated.
Tactical Strategy Recommendations
Trading Strategy
- Options Play: Buy short-dated (Jan 26) $550 calls for leverage on a Beat. The stock has room to rebound post-pre-announcement dip.
- Pairs Trade: Long ISRG vs. Short smaller robotic surgery peers (e.g., ASXC) due to ISRG’s dominant market position and Dv5 tailwinds.
- Hedge: Sell upside calls above $570 to capitalize on volatility compression post-earnings.
Rationale: Fact Data supports a Beat, but elevated valuations (per Citi/Freedom) limit upside. Focus on tactical options plays and hedging.
Earnings Surprise Analysis
ISRG Transcript
The earnings call reflects positive financial performance with increased net income, EPS, and deposit growth. The guidance adjustments for da Vinci procedures and gross profit margin are optimistic, and the Q&A indicates rational market competition. Despite some concerns about special mention loans, the overall sentiment is positive, with management providing clear responses. The positive factors outweigh negatives, suggesting a likely stock price increase within 2% to 8% over the next two weeks.
The earnings call summary indicates positive developments: increased guidance for da Vinci procedures and gross profit margins, a strategic focus on expanding minimally invasive cardiac procedures, and leveraging advanced imaging and ASC opportunities. Despite competitive pressures in China, the company is adapting well, with promising SP system growth and new digital offerings. While management avoided specific 2026 projections, the overall sentiment remains optimistic, supported by procedure growth and strategic initiatives. The absence of market cap data limits precise prediction, but the positive guidance and strategic direction suggest a positive stock reaction.
The earnings call highlights strong growth in procedure volumes and successful adoption of the da Vinci 5 system, indicating positive market reception. Despite challenges in the bariatric and China markets, guidance updates reflect strategic adaptability. The Q&A section provides additional insights into growth areas like alternative care sites and new platforms, supporting a positive outlook. However, management's lack of clarity on certain issues tempers the sentiment slightly. Overall, the combination of strong financial performance, strategic initiatives, and positive guidance adjustments suggests a positive stock price movement.
ISRG Report
Frequently Asked Questions
What is the Intuitive Surgical Inc FY2025Q4 Earnings Release Date and Time?
Intuitive Surgical Inc (ISRG) is scheduled to release its FY2025Q4 earnings report onJan 22, 2026, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Intuitive Surgical Inc FY2025Q4 Revenue and EPS?
Analysts' consensus predicts 3.00B in revenue and an EPS of 2.00 for Intuitive Surgical Inc's FY2025Q4.
What Does Intellectia's AI Predict for Intuitive Surgical Inc FY2025Q4 Earnings?
Intellectia's exclusive AI algorithms forecast a Beat forIntuitive Surgical Inc's FY2025Q4 earnings, with a prediction date of Jan 22, 2026. Intuitive Surgical Inc The earnings forecast indicates a Beat driven by strong procedure growth and system utilization improvements, though elevated valuations may limit the upside.
How Can I Use This Earnings Prediction to Trade ISRG Stock?
Leverage Intellectia's AI forecast to position trades ahead of theJan 22, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Intuitive Surgical Inc FY2025Q4?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
